What is NTRB's earnings growth forecast for 2026-2026?
(NASDAQ: NTRB) Nutriband's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.42%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.25%.
Nutriband's earnings in 2025 is -$9,973,409.
In 2026, NTRB is forecast to generate -$6,246,336 in earnings, with the lowest earnings forecast at -$6,246,336 and the highest earnings forecast at -$6,246,336.
What is NTRB's revenue growth forecast for 2026-2026?
(NASDAQ: NTRB) Nutriband's forecast annual revenue growth rate of 321.68% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.33%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.78%.
Nutriband's revenue in 2025 is $2,398,437.
In 2026, NTRB is forecast to generate $154,619,118 in revenue, with the lowest revenue forecast at $154,619,118 and the highest revenue forecast at $154,619,118.
What is NTRB's forecast return on assets (ROA) for 2026-2028?
(NASDAQ: NTRB) forecast ROA is 663.57%, which is higher than the forecast US Biotechnology industry average of 47.5%.
What is NTRB's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: NTRB) Nutriband's current Earnings Per Share (EPS) is -$0.90. In 2026, NTRB's EPS is forecast to hit -$0.56 (min: -$0.56, max: -$0.56).
What is NTRB's forecast return on equity (ROE) for 2026-2028?
(NASDAQ: NTRB) forecast ROE is 799.94%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.